Links
[1] https://www.msh.org/resources/accredited-drug-seller-initiatives-publication-compendium-2009%E2%80%932017?page=32
[2] https://www.msh.org/resources/accredited-drug-seller-initiatives-publication-compendium-2009%E2%80%932017
[3] https://www.msh.org/resources/quality-iptp-checklist-for-facility-officers-in-charge?page=32
[4] https://www.msh.org/resources/quality-iptp-checklist-for-facility-officers-in-charge
[5] https://www.msh.org/resources/malaria-in-pregnancy-improving-access-and-use-of-quality-preventive-treatment?page=32
[6] https://www.msh.org/resources/gender-transformative-supportive-supervision-framework-and-technical-brief?page=32
[7] https://www.msh.org/resources/gender-transformative-supportive-supervision-framework-and-technical-brief
[8] https://www.msh.org/resources/leaders-who-govern-companion-guide?page=32
[9] https://www.msh.org/resources/leaders-who-govern-companion-guide
[10] https://www.msh.org/resources/pre-service-integration-guide?page=32
[11] https://www.msh.org/resources/pre-service-integration-guide
[12] https://www.msh.org/resources/network-strengthening-program-nsp?page=32
[13] https://www.msh.org/resources/network-strengthening-program-nsp
[14] https://www.msh.org/resources/ready-together-conference-program?page=32
[15] https://www.msh.org/resources/methods-used-in-prevalence-studies-of-disrespect-and-abuse-during-facility-based?page=32
[16] https://www.msh.org/resources/applying-a-new-framework-for-public-health-systems-recovery-following-emergencies-and?page=32
[17] https://www.msh.org/resources/contraceptive-implant-discontinuation-in-huambo-and-luanda-angola-a-qualitative?page=32
[18] https://www.msh.org/resources/the-provision-of-emergency-contraception-in-kinshasas-private-sector-pharmacies?page=32
[19] https://www.msh.org/resources/combating-antimicrobial-resistance-with-stronger-health-systems?page=32
[20] https://www.msh.org/resources/combating-antimicrobial-resistance-with-stronger-health-systems
[21] https://www.msh.org/resources/evaluating-global-health-partnerships-a-case-study-of-a-gavi-hpv-vaccine-application?page=32
[22] https://www.msh.org/resources/understanding-the-unique-experiences-perspectives-and-sexual-and-reproductive-health-needs?page=32
[23] https://www.msh.org/resources/antimicrobial-resistance-an-online-course?page=32
[24] https://www.msh.org/resources/operational-aspects-of-bedaquiline-implementation-in-swaziland-report-from-the-field?page=32
[25] https://www.msh.org/resources/hiv-infected-adolescents-have-low-adherence-to-antiretroviral-therapy-a-cross-sectional?page=32
[26] https://www.msh.org/resources/family-planning-fact-sheet?page=32
[27] https://www.msh.org/resources/family-planning-fact-sheet
[28] https://www.msh.org/resources/pharmaceutical-management-considerations-for-expanded-coverage-of-essential-health?page=32
[29] https://www.msh.org/resources/pharmaceutical-management-considerations-for-expanded-coverage-of-essential-health
[30] https://www.msh.org/resources/implementing-tb-activities-in-emergency-settings-south-sudan?page=32
[31] https://www.msh.org/resources/implementing-tb-activities-in-emergency-settings-south-sudan
[32] https://www.msh.org/resources/coordinated-procurement-distribution-system-news?page=32
[33] https://www.msh.org/resources/coordinated-procurement-distribution-system-news
[34] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan?page=32
[35] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan
[36] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan?page=32
[37] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan
[38] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019?page=32
[39] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019
[40] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial
[41] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=31
[42] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=28
[43] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=29
[44] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=30
[45] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=33
[46] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=34
[47] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=35
[48] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=36
[49] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=56